No just just some realistic timeliness I've seen i
Post# of 144714
![](/assets/46931549/no_avatar_available_thumb.jpg)
So Mrk's Keytruda the most successful cancer drug out there,$10B per year and climbing, has to do a P3 for each type of cancer even though it is a platform type cancer drug. But little old CYDY that has a great relationship with the FDA is just going to walk away in 6 months with a BTD and approval.
Could BTD push up approval yes, by how much we don't know.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)